Skip to main content
. 2013 Apr 19;5(4):1336–1348. doi: 10.3390/nu5041336

Figure 2.

Figure 2

Proportion of patients with (A) ≥30% reduction of iPTH from baseline, (B) achieving treatment target of iPTH recommended by the Kidney Disease Outcomes Quality Initiative (K/DOQI) and, (C) by Kidney Disease: Improving Global Outcomes (KDIGO) after 6 months of treatment.